WO2000051548A3 - COMPOSITIONS AND METHODS FOR THEIR PREPARATION FROM $i(LEPIDIUM) - Google Patents
COMPOSITIONS AND METHODS FOR THEIR PREPARATION FROM $i(LEPIDIUM) Download PDFInfo
- Publication number
- WO2000051548A3 WO2000051548A3 PCT/US2000/005607 US0005607W WO0051548A3 WO 2000051548 A3 WO2000051548 A3 WO 2000051548A3 US 0005607 W US0005607 W US 0005607W WO 0051548 A3 WO0051548 A3 WO 0051548A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- methods
- lepidium
- preparation
- isolation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Gynecology & Obstetrics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00917719A EP1180006A4 (en) | 1999-03-03 | 2000-03-03 | Compositions and methods for their preparation from lepidium |
CA2362858A CA2362858C (en) | 1999-03-03 | 2000-03-03 | Compositions and methods for their preparation from lepidium |
AU38649/00A AU3864900A (en) | 1999-03-03 | 2000-03-03 | Compositions and methods for their preparation from (lepidium) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/261,806 US6267995B1 (en) | 1999-03-03 | 1999-03-03 | Extract of Lepidium meyenii roots for pharmaceutical applications |
US09/261,806 | 1999-03-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000051548A2 WO2000051548A2 (en) | 2000-09-08 |
WO2000051548A3 true WO2000051548A3 (en) | 2001-11-15 |
Family
ID=22994957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/005607 WO2000051548A2 (en) | 1999-03-03 | 2000-03-03 | COMPOSITIONS AND METHODS FOR THEIR PREPARATION FROM $i(LEPIDIUM) |
Country Status (5)
Country | Link |
---|---|
US (5) | US6267995B1 (en) |
EP (1) | EP1180006A4 (en) |
AU (1) | AU3864900A (en) |
CA (1) | CA2362858C (en) |
WO (1) | WO2000051548A2 (en) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6267995B1 (en) | 1999-03-03 | 2001-07-31 | Pure World Botanicals, Inc. | Extract of Lepidium meyenii roots for pharmaceutical applications |
US20070054001A1 (en) * | 2003-12-22 | 2007-03-08 | Santerra Pharmaceuticals, Inc. | Methods and compositions to enhance endogenous igf production and their uses |
US20040137131A1 (en) * | 1999-09-03 | 2004-07-15 | Bobrowski Paul J. | Maca products and their uses |
CN1320886C (en) | 2002-05-17 | 2007-06-13 | 杜克大学 | Method for treating obesity |
WO2004071437A2 (en) * | 2003-02-07 | 2004-08-26 | Barmensen, Inc. | Compositions for enhancing sexual responsiveness |
TW200529864A (en) * | 2004-01-28 | 2005-09-16 | Suntory Ltd | Method for producing maca extract |
JP3747049B2 (en) * | 2004-03-30 | 2006-02-22 | サントリー株式会社 | Alcoholic beverage containing maca extract |
JP2005281271A (en) * | 2004-03-31 | 2005-10-13 | Suntory Ltd | Skin moisturizing ability improving agent |
JP2005281272A (en) * | 2004-03-31 | 2005-10-13 | Suntory Ltd | Peripheral blood stream improving agent |
JP2007112782A (en) * | 2004-12-22 | 2007-05-10 | Towa Corporation 株式会社 | Estrogen-increasing composition, estrogen-increasing food, estrogen-increasing medicament, and progesterone-increasing composition |
JP4627477B2 (en) * | 2005-10-07 | 2011-02-09 | サントリーホールディングス株式会社 | Maca extract-containing food and drink containing acetic acid or vinegar |
KR100814133B1 (en) | 2006-12-05 | 2008-03-18 | 주식회사 내추럴하우스 | Method for maca extracts with high content of macamide |
KR101346884B1 (en) * | 2011-10-17 | 2014-01-06 | (주)풀무원홀딩스 | Composition for preventing and improving inflammatory bowel diseases and anti-fatigue comprising extract of maca as an active ingredient |
ES2604356T3 (en) | 2011-12-14 | 2017-03-06 | Yeda Research And Development Co. Ltd. | Subpopulation of human monocytes for the treatment of lesions of the central nervous system |
CN103275012B (en) * | 2013-06-08 | 2015-07-01 | 中国科学院过程工程研究所 | Preparation method and application of Maca alkaloid |
CN104513173B (en) * | 2013-09-30 | 2018-03-06 | 中国科学院过程工程研究所 | A kind of Maca extract, Its Preparation Method And Use |
CN103864949B (en) * | 2014-03-20 | 2016-02-03 | 北京中科健宇生物科技有限公司 | Membrane separation technique is utilized to prepare maca polysaccharide, the alkaloidal method of agate coffee |
CN105146511A (en) * | 2015-07-31 | 2015-12-16 | 昆明博尚生物技术有限公司 | Processing method for improving specific active components of Peruvian ginseng |
CN105367677A (en) * | 2015-12-01 | 2016-03-02 | 中国药科大学 | Maca polysaccharide of immunoregulatory activity and preparation method therefor |
CN105348357B (en) * | 2015-12-03 | 2017-06-09 | 中国科学院过程工程研究所 | A kind of maca saponin, its preparation method and application |
CN105853491B (en) * | 2016-04-29 | 2019-12-03 | 杭州纳趣实业有限公司 | A method of the composition is prepared with the composition for promoting fecundity function and by raw material of maca |
DE202023001867U1 (en) | 2023-09-03 | 2023-10-17 | Penta Phi Eg | Formulation comprising at least one type of cress |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0812565A (en) * | 1994-06-29 | 1996-01-16 | Shiseido Co Ltd | Skin external preparation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6267995B1 (en) | 1999-03-03 | 2001-07-31 | Pure World Botanicals, Inc. | Extract of Lepidium meyenii roots for pharmaceutical applications |
-
1999
- 1999-03-03 US US09/261,806 patent/US6267995B1/en not_active Expired - Lifetime
-
2000
- 2000-03-03 CA CA2362858A patent/CA2362858C/en not_active Expired - Fee Related
- 2000-03-03 EP EP00917719A patent/EP1180006A4/en not_active Ceased
- 2000-03-03 WO PCT/US2000/005607 patent/WO2000051548A2/en active Application Filing
- 2000-03-03 AU AU38649/00A patent/AU3864900A/en not_active Abandoned
-
2001
- 2001-06-08 US US09/878,141 patent/US20020042530A1/en not_active Abandoned
- 2001-10-19 US US10/002,757 patent/US6428824B1/en not_active Expired - Lifetime
-
2002
- 2002-05-02 US US10/138,030 patent/US6552206B1/en not_active Ceased
-
2007
- 2007-11-21 US US11/943,867 patent/USRE43005E1/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0812565A (en) * | 1994-06-29 | 1996-01-16 | Shiseido Co Ltd | Skin external preparation |
Non-Patent Citations (4)
Title |
---|
COMAS M. ET AL.: "Estudio bromatologico De La Maca O Paca", ALIMENTARIA, vol. 286, 1997, pages 85 - 90, XP002942756 * |
DINI A. ET AL.: "Chemical composition of lepidium meyenii", FOOD CHEMISTRY, vol. 49, no. 4, 1994, pages 347 - 349, XP002942757 * |
JOHNS T.: "The Anu and the Maca", JOURNAL OF ENTHNOBIOLOGY, vol. 1, no. 2, 1981, pages 208 - 212, XP002942758 * |
See also references of EP1180006A4 * |
Also Published As
Publication number | Publication date |
---|---|
US6428824B1 (en) | 2002-08-06 |
EP1180006A4 (en) | 2004-06-16 |
US6552206B1 (en) | 2003-04-22 |
US20020042530A1 (en) | 2002-04-11 |
EP1180006A2 (en) | 2002-02-20 |
CA2362858A1 (en) | 2000-09-08 |
WO2000051548A2 (en) | 2000-09-08 |
CA2362858C (en) | 2010-12-21 |
US6267995B1 (en) | 2001-07-31 |
AU3864900A (en) | 2000-09-21 |
US20030068388A1 (en) | 2003-04-10 |
USRE43005E1 (en) | 2011-12-06 |
US20020061341A1 (en) | 2002-05-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000051548A3 (en) | COMPOSITIONS AND METHODS FOR THEIR PREPARATION FROM $i(LEPIDIUM) | |
HUP0101268A3 (en) | Pharmaceutical compositions for treating female sexual dysfunction | |
HK1039328A1 (en) | Pyrazolopyrimidinone derivatives for the treatment of impotence | |
WO2001079458A3 (en) | Polypeptides having haloperoxidase activity | |
WO2002002565A3 (en) | Glucocortiocoid-selective antiinflammatory agents | |
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
WO2000010507A3 (en) | Use of melanin for inhibition of angiogenesis and macular degeneration | |
AU3764901A (en) | Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom | |
IL153676A0 (en) | Liposomal pharmaceutical compositions | |
PL345215A1 (en) | Novel form of irbesartan, methods for obtaining said form and pharmaceutical compositions containing same | |
IL137509A0 (en) | Glucocorticoid-selective anti-inflammatory agents | |
UA72909C2 (en) | Cinnamide derivatives useful in the treatment of inflammatory and immune diseases, a composition containing such derivatives and a method for the preparation of cinnamide derivatives | |
AU6949800A (en) | Compositions and methods for the treatment of sepsis using antibodies to c5a | |
IL139751A0 (en) | Compositions comprising organic mono-or dinitrate for treating impotence | |
AU2001250821A1 (en) | Methods and compositions for the treatment and prevention of erectile dysfunction | |
WO1999052543A3 (en) | Pharmaceutical compositions comprising erythropoietin for treatment of cancer | |
WO2001079164A3 (en) | N-substituted dithiocarbamates for the treatment of biological disorders | |
WO2002091858A8 (en) | Anxiolytic marcgraviaceae compositions containing betulinic acid, betulinic acid derivatives, and methods | |
MXPA01003501A (en) | Method to mitigate plant stress. | |
AU3632600A (en) | Compositions and methods for the treatment of immune related diseases | |
ZA200003768B (en) | Methods and compositions for treating diseases and conditions of the eye. | |
ZA200002038B (en) | Plant protection treatment of plants and compositions which can be used for this purpose. | |
WO2000053231A3 (en) | Fatty acid-anticancer conjugates and uses thereof | |
HUP0003219A3 (en) | Phthalazine derivatives, process for producing them and pharmaceutical compositions containing them and use of the compounds for producing pharmaceutical compositions useful for treating erectile dysfunction | |
AU3048501A (en) | An improved pharmaceutical composition for treating male erectile dysfunction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2362858 Country of ref document: CA Ref country code: CA Ref document number: 2362858 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000917719 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2000917719 Country of ref document: EP |